BioNTech SE on LinkedIn: Pfizer and BioNTech Report New Data on Omicron BA.4 /BA.5-Adapted Bivalent…
![News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/omicron-ba5-chmp.jpg?__blob=thumbnail&v=6)
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
Pfizer Canada - Another step forward in the fight against COVID-19: Health Canada has authorized COMIRNATY Original & Omicron BA.4/BA.5 (Pfizer-BioNTech bivalent, Omicron BA.4/BA.5-adapted COVID-19 vaccine) as a booster dose for Canadians
![Clinical data shows Pfizer, BioNTech Omicron BA.4/BA.5 booster offers higher protection in adults - Homeland Preparedness News Clinical data shows Pfizer, BioNTech Omicron BA.4/BA.5 booster offers higher protection in adults - Homeland Preparedness News](https://homelandprepnews.com/wp-content/uploads/2022/11/shutterstock_1884506980.jpg)
Clinical data shows Pfizer, BioNTech Omicron BA.4/BA.5 booster offers higher protection in adults - Homeland Preparedness News
![Antibody response from Omicron BA.4/BA.5 bivalent booster no better than original vaccine - Hospital Pharmacy EuropeHospital Pharmacy Europe Antibody response from Omicron BA.4/BA.5 bivalent booster no better than original vaccine - Hospital Pharmacy EuropeHospital Pharmacy Europe](https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Antibody-response-from-Omicron-BA.4-BA.5-bivalent-booster-no-better-than-original-vaccine.gif)